A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery
Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
To investigate the efficiency and safety of SOX or SP adjuvant chemotherapy to phase II and
III gastric cancer patients after D2 surgery. If SOX is equal to SP in efficiency and less
toxicity.